GB Patent

GB8707421D0 — Pharmaceutical formulations

Assigned to Wellcome Foundation Ltd · Expires 1987-04-29 · 39y expired

What this patent protects

The invention relates to pharmaceutical formulations comprising discrete units of zidovudine provided with a controlled release coating in which the said units are preferably in the form of spheroids.

USPTO Abstract

The invention relates to pharmaceutical formulations comprising discrete units of zidovudine provided with a controlled release coating in which the said units are preferably in the form of spheroids.

Drugs covered by this patent

Patent Metadata

Patent number
GB8707421D0
Jurisdiction
GB
Classification
—
Expires
1987-04-29
Drug substance claim
No
Drug product claim
No
Assignee
Wellcome Foundation Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.